Cardio-visual Stimulation in Augmented Reality for Pain Reduction (HEART)
Regional Pain Syndrome, Chronic Pain Syndrome
About this trial
This is an interventional treatment trial for Regional Pain Syndrome
Eligibility Criteria
Inclusion Criteria:
- Be over 18 years of age
- Present permanent chronic pain (for more than 3 months), secondary to a peripheral pathology (traumatic, orthopedic or neurological), located in the hand or forearm.
Exclusion Criteria:
- Pregnant women
- People in emergency situations
- Persons unable to give informed consent
- Persons who are mentally or linguistically unable to understand the research test instructions
- Individuals who are not available to complete the entire study protocol
- Cognitive impairments that prevent the use of the equipment
- Psychiatric disorders
- Patients with seizure disorders
- Patients with central hemineglect
- Pain secondary to central nervous system pathology
- Patients with arrhythmia
- Patients with head tremors or head shaking.
Sites / Locations
- Institut Régional de Médecine Physique et de RéadaptationRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Experimental 1: HEART - Placebo - HEART - Placebo
Experimental 2: HEART - Placebo - Placebo - HEART
Experimental 3: Placebo - HEART - Placebo - HEART
Experimental 4: Placebo - HEART - HEART - Placebo
The patient receives visual feedback in an augmented reality environment in four session, over two weeks. Week 1: HEART, Placebo (after >24hour washout) Week 2: HEART, Placebo (after >24hour washout)
The patient receives visual feedback in an augmented reality environment in four session, over two weeks. Week 1: HEART, Placebo (after >24hour washout) Week 2: Placebo, HEART (after >24hour washout)
The patient receives visual feedback in an augmented reality environment in four session, over two weeks. Week 1: Placebo, HEART (after >24hour washout) Week 2: Placebo, HEART (after >24hour washout)
The patient receives visual feedback in an augmented reality environment in four session, over two weeks. Week 1: HEART, Placebo (after >24hour washout) Week 2: Placebo, HEART (after >24hour washout)